HRI awarded at ASMR meeting
Congratulations to Manisha Patil, Bob Lee and Dr Richard Tan on receiving awards at the Australian Society for Medical Research (ASMR) Annual Scientific Meeting on Friday 31 May.
HRI speaks to Channel 7 News
Preeclampsia (high blood pressure during pregnancy) is the leading cause of stillbirths and newborn deaths in Australia. It also doubles a woman’s risk of heart disease and stroke later in life.
HRI's Professor Annemarie Hennessy talks to Channel 7 News about preeclampsia.
Nano ‘junk’ could save lives
Scientists at the Heart Research Institute in Sydney have developed a simple, cheap and efficient way to collect nanoparticles that can be used in the treatment of cancer, cardiovascular disease and Alzheimer’s.
HRI calls on Aussies to support mums-to-be
In Australia, cardiovascular disease continues to take the lives of 22 females every day – killing almost three times more women than breast cancer. Preeclampsia and gestational diabetes developed during pregnancy can significantly increase a woman’s risk of heart disease later in life, but these can be manageable complications if monitored.
Professor Annemarie Hennessy AM named Distinguished Professor
Congratulations to Professor Annemarie Hennessy AM, recently named Distinguished Professor by Western Sydney University.
Celebrating 30 Years of Discovery
In March, HRI celebrated 30 years of groundbreaking research and new discoveries that have contributed to an improved understanding of cardiovascular disease.
HRI welcomes Government’s commitment to medical research
The Federal Government has reaffirmed its commitment in the Budget to fully fund the Medical Research Future Fund (MRFF).
New publication in Nature Materials
A new paper on how biomechanical thrombus growth is mediated has been published by the HRI team led by Prof Shaun Jackson and Dr Arnold (Lining) Ju in Nature Materials.
Australian scientists pursue implant ‘Holy Grail’
HRI researchers are a step closer to an exciting future where the human body does not reject lifesaving coronary bypass implants, a new study reveals.